Assessment of daily profiles of ADHD and ODD symptoms, and symptomatology related to ADHD medication, by parent and teacher ratings
Authors:
Open Access
- 8 September 2011
- journal article
- supplement
- Published by Springer Nature in European Child & Adolescent Psychiatry
- Vol. 20 (2) , 289-296
Abstract
DAYAS is a new two-part rating scale that assesses: (1) ADHD and ODD symptoms (externalising symptom ratings) and (2) symptomatology potentially related to ADHD medication (potentially medication-related symptoms) in real-world settings at different time periods throughout a normal school day. Data from a proof-of-concept study and two observational trials (Medikinet® retard [methylphenidate] and the Equasym XL® [methylphenidate] OBSEER study) evaluated: (1) validity of weekly externalising symptom ratings using DAYAS, in place of daily ratings; (2) reliability and internal consistency of DAYAS ratings for externalising symptoms and potentially medication-related symptoms; and (3) convergent and divergent validity of the externalising symptom ratings with existing validated scales. From the proof-of-concept study, daily scores by period of day and during the whole day correlated strongly with equivalent weekly scores (r = 0.83–0.92). Internal consistency of externalising symptom rating scales calculated from pooled data were acceptable or good by period of day (Cronbach’s alpha = 0.68–0.90) and very high for whole day scores (Cronbach’s alpha = 0.88–0.95). Internal consistency of the rating scale for potentially medication-related symptoms was also good for both teacher and parent ratings. From OBSEER data, correlations between FBB-ADHD total symptom scores and ratings on both parent and teacher versions of DAYAS were high (r = 0.73 and r = 0.84, respectively). Correlations between DAYAS and SDQ were highest for the SDQ subscales hyperactivity and conduct problems and substantially lower for pro-social behaviour, peers and emotional problems. The DAYAS rating scale had good internal consistency, and DAYAS scores correlated well with existing validated scales and the SDQ subscales hyperactivity and conduct problems. Weekly DAYAS scores (whole day and by period of day) could be considered a suitable replacement for daily assessment scores.Keywords
This publication has 16 references indexed in Scilit:
- Comparison of the Efficacy of Two Different Modified Release Methylphenidate Preparations for Children and Adolescents with Attention-Deficit/Hyperactivity Disorder in a Natural Setting: Comparison of the Efficacy of Medikinet ® Retard and Concerta ® —a Randomized, Controlled, Double-Blind Multicenter Clinical Crossover TrialJournal of Child and Adolescent Psychopharmacology, 2011
- An observational study of once-daily modified-release methylphenidate in ADHD: effectiveness on symptoms and impairment, and safetyEuropean Child & Adolescent Psychiatry, 2011
- Methylphenidat mit modifizierter Freisetzung in der RoutineversorgungMonatsschrift Kinderheilkunde, 2011
- Psychometric properties of two ADHD questionnaires: comparing the Conners’ scale and the FBB-HKS in the general population of German children and adolescents – results of the BELLA studyEuropean Child & Adolescent Psychiatry, 2008
- The Worldwide Prevalence of ADHD: A Systematic Review and Metaregression AnalysisAmerican Journal of Psychiatry, 2007
- Attention-deficit hyperactivity disorderThe Lancet, 2005
- Comparative efficacy of once?a?day extended?release methylphenidate, two?times?daily immediate?release methylphenidate, and placebo in a laboratory school settingEuropean Child & Adolescent Psychiatry, 2004
- EditorialEuropean Child & Adolescent Psychiatry, 2004
- A 14-Month Randomized Clinical Trial of Treatment Strategies for Attention-Deficit/Hyperactivity DisorderArchives of General Psychiatry, 1999
- Clinical Studies of Methylphenidate Serum Levels in Children and AdultsJournal of the American Academy of Child Psychiatry, 1982